Letters to the Editor

Systemic sclerosis and inflammatory myopathy after treatment with durvalumab in a patient with rectal neoplasm

I. Villanueva¹, J. Cívico², G.M. Lledó³, A. Matas⁴, I. Aldecoa⁵, J. Milisenda⁶, G. Espinosa⁷

Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Spain.
Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Spain.
Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Spain.
Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, Universitat de Barcelona, Spain.
Pathology Deparment, Hospital Clínic, Universitat de Barcelona, Spain.
Muscle Research Unit, Department of Internal Medicine, Hospital Clinic, Universitat de Barcelona, Spain.
Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Spain. gespino@clinic.cat

CER17885
2024 Vol.42, N°8
PI 1704, PF 1705
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 39058478 [PubMed]

Received: 29/05/2024
Accepted : 18/07/2024
In Press: 26/07/2024
Published: 14/08/2024